Increased expression of <i>MCM4</i> is associated with poor prognosis in patients with hepatocellular carcinoma.

Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma.

Zheng, Ruinian; Lai, Guowei; Li, Rongfa; Hao, Yanyan; Cai, Limin; Jia, Jun.

Afiliação

Zheng R; Department of Oncology, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Lai G; Department of General Surgery, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Li R; Department of General Surgery, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Hao Y; Department of Oncology, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Cai L; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.
Jia J; Department of Oncology, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.

J Gastrointest Oncol ; 12(1): 153-173, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33708433

Palavras-chave

Minichromosome maintenance complex component 4 (MCM4); cancer progression; clinical outcomes; hepatocellular carcinoma (HCC); multiomics analysis; survival

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article